OpenUnited Kingdom
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Key facts
- Buyer
- NHS England, Leeds
- Country
- United Kingdom
- Region
- UKI45
- Estimated value
- £35.5M
- Published
- Source
- UK Find a Tender
Description
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20…
Summary and why it fits you — in your account
Subscribers get a short summary in their language and an explanation of how the tender matches their searches.
Open in your accountOpen on the platform: UK Find a TenderLeaves this site. Terms of participation and documents are there.
Get tenders like this every day
Save a search for the category and new tenders reach your inbox or Telegram before your competitors see them. 5 days free.
No card. Your first saved search is already set up.